Q3 2015 13F Holders as of 30 Sep 2015
-
Type / Class
-
Debt / NOTE 2.500% 2/1
-
Market price (% of par)
-
161.16%
-
Total 13F principal
-
$197,332,000
-
Principal change
-
+$3,289,000
-
Total reported market value
-
$320,216,000
-
Number of holders
-
25
-
Value change
-
-$11,572,212
-
Number of buys
-
12
-
Number of sells
-
10
Institutional Holders of AMAG PHARMACEUTICALS INC - NOTE 2.500% 2/1 as of Q3 2015
As of 30 Sep 2015,
AMAG PHARMACEUTICALS INC - NOTE 2.500% 2/1 was held by
25 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$197,332,000
in principal (par value) of the bond.
The largest 10 bondholders included
CITADEL ADVISORS LLC, WOLVERINE ASSET MANAGEMENT LLC, Castle Creek Arbitrage, LLC, Hudson Bay Capital Management LP, Polar Asset Management Partners Inc., Linden Advisors LP, Hutchin Hill Capital, LP, Calamos Advisors LLC, CSS LLC/IL, and Luxor Capital Group, LP.
This page lists
25
institutional bondholders reporting positions
for the Q3 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.